The Surgical Stents Market size was valued at USD 10.03 Billion in 2022 and is projected to reach USD 17.56 Billion by 2030, growing at a CAGR of 7.5% from 2024 to 2030.
The surgical stents market is segmented based on the application of stents, which primarily include uses in hospitals and clinics. These applications are critical to understanding the dynamics and growth of the stents industry. The demand for stents in hospitals and clinics is driven by the increasing prevalence of chronic diseases, such as cardiovascular diseases, urological disorders, and gastrointestinal issues. Hospitals, which provide specialized treatments and surgical procedures, are one of the largest consumers of surgical stents. These medical institutions typically deal with complex cases that require the use of stents to support patients in recovering from conditions like blocked arteries or other vascular issues. Stents are used in a variety of procedures, such as angioplasty, to ensure that patients' blood vessels remain open and functional post-surgery.
Clinics, particularly outpatient centers, also contribute significantly to the surgical stent market. While the volume of procedures conducted in clinics may be lower than in hospitals, the number of patients requiring less-invasive procedures has been on the rise. Clinics typically deal with patients who need minimally invasive interventions for managing vascular or urological conditions, often in an outpatient setting. The stents used in these cases are smaller and designed for easier, less invasive insertion. As the demand for outpatient services increases, the market for surgical stents within clinics is expected to grow at a steady pace, driven by advancements in stent technology that make procedures more efficient and less traumatic for patients.
The hospital subsegment in the surgical stents market is a major driver of growth in the industry. Hospitals are equipped with advanced medical technologies and highly trained professionals capable of handling complex surgeries, including those that require the implantation of stents. A significant portion of the demand for surgical stents comes from the cardiovascular field, where stents are used to treat coronary artery diseases and other vascular conditions. These procedures, which are often life-saving, rely heavily on stents to maintain the patency of blood vessels, preventing life-threatening blockages and improving blood flow. Hospitals are also the primary settings for surgeries that use stents in other areas of the body, such as the urinary tract and gastrointestinal system.
Given the complex nature of procedures performed in hospitals, the demand for stents in this segment continues to grow. Technological advancements have enabled hospitals to offer minimally invasive procedures, reducing recovery times and improving patient outcomes. As the incidence of chronic diseases such as heart disease and diabetes rises globally, the need for hospitals to provide stent-related surgeries is also expected to increase. Moreover, hospitals tend to have high rates of stent utilization due to their capacity to handle both urgent and elective cases, making them essential players in the surgical stents market. Furthermore, the rise in hospital-based surgical procedures involving stents is anticipated to continue, as healthcare providers focus on improving treatment efficiency and patient care.
The clinics subsegment represents a rapidly growing market within the overall surgical stents market. Clinics, typically focusing on outpatient care, are seeing increasing numbers of patients who require surgical stents for various conditions, including cardiovascular diseases, urological issues, and even gastrointestinal disorders. The key advantage of clinics in this context is their ability to perform less invasive procedures, often in an outpatient setting, which reduces hospital stays and overall treatment costs. Clinics are particularly important for patients seeking non-emergency, elective procedures, or those who need a quick recovery process. The stents used in these settings are designed for minimal discomfort and fast recovery, which is a primary consideration in outpatient surgery.
The expansion of outpatient surgical options is a significant driver of the stents market within clinics. As medical technology advances, more sophisticated stents that require minimal recovery time are becoming available, further propelling the growth of this subsegment. Moreover, as healthcare systems become increasingly focused on reducing patient length of stay and improving the overall efficiency of care, the use of stents in clinics will continue to rise. Clinics offer more affordable care options, and as patients become more aware of minimally invasive procedures, they are more likely to seek treatment in these settings, boosting the demand for stents in clinic-based procedures.
Download In depth Research Report of Surgical Stents Market
By combining cutting-edge technology with conventional knowledge, the Surgical Stents market is well known for its creative approach. Major participants prioritize high production standards, frequently highlighting energy efficiency and sustainability. Through innovative research, strategic alliances, and ongoing product development, these businesses control both domestic and foreign markets. Prominent manufacturers ensure regulatory compliance while giving priority to changing trends and customer requests. Their competitive advantage is frequently preserved by significant R&D expenditures and a strong emphasis on selling high-end goods worldwide.
Abbott
B. Braun Melsungen
Boston Scientific
Stryker
STI Laser Industries
ELLA-CS
Laserage Technology
amg International GmbH
Meril
Elixir Medical
Abbott
Amaranth Medical
Arterial Remodeling Technologies
Angiocare
North America (United States, Canada, and Mexico, etc.)
Asia-Pacific (China, India, Japan, South Korea, and Australia, etc.)
Europe (Germany, United Kingdom, France, Italy, and Spain, etc.)
Latin America (Brazil, Argentina, and Colombia, etc.)
Middle East & Africa (Saudi Arabia, UAE, South Africa, and Egypt, etc.)
For More Information or Query, Visit @ Surgical Stents Market Size And Forecast 2024-2030
The surgical stents market is witnessing several significant trends that are shaping its future growth. One of the primary trends is the development of bioabsorbable and drug-eluting stents. These stents are designed to dissolve or degrade over time, eliminating the need for long-term stent retention and reducing the risk of complications such as in-stent restenosis. The use of drug-eluting stents, in particular, has become a standard in many cardiovascular procedures, as these stents release medication that helps prevent the re-narrowing of arteries. These technological innovations are expected to drive the demand for surgical stents as they offer more effective treatment options and improved patient outcomes.
Another key trend is the growing focus on minimally invasive surgeries. Stent procedures are increasingly being performed using endovascular techniques, which involve smaller incisions and quicker recovery times. The shift toward minimally invasive surgery is driven by the benefits of reduced patient discomfort, shorter hospital stays, and lower healthcare costs. With advancements in imaging and navigation technologies, surgeons can place stents more accurately, further enhancing the appeal of stent procedures in both hospital and clinic settings. This trend is expected to continue as healthcare providers aim to offer more effective and patient-friendly treatment options.
The surgical stents market presents numerous opportunities for growth, particularly as the demand for stent-based procedures continues to rise. One significant opportunity is the increasing prevalence of chronic diseases, such as cardiovascular diseases, diabetes, and urological disorders. As these conditions become more common globally, the need for stent interventions to manage these diseases is expected to increase, creating a substantial market for surgical stents. Additionally, the aging population is contributing to the growth of the market, as older individuals are more likely to experience the conditions that require stent placement.
Another opportunity lies in the continued advancements in stent technology. Companies that invest in the development of new and improved stents, such as those that are bioresorbable or drug-eluting, are likely to benefit from strong market demand. As the medical industry shifts toward more efficient, cost-effective, and minimally invasive procedures, there is a growing need for innovative stent solutions that improve patient outcomes. Furthermore, expanding access to healthcare in developing countries provides another avenue for growth in the surgical stents market, as these regions experience rising healthcare needs and greater access to advanced medical technologies.
What is a surgical stent used for?
A surgical stent is used to keep a blocked or narrowed passage open, such as arteries, blood vessels, or ducts, after surgery or to prevent a blockage from recurring.
How long do surgical stents last?
The longevity of a stent depends on the type used, with some bioabsorbable stents dissolving over time and others designed to remain in place indefinitely.
Are there risks associated with surgical stents?
Yes, there can be risks such as infection, blood clots, or restenosis, depending on the type of stent and the procedure performed.
What types of stents are used in hospitals?
Hospitals commonly use drug-eluting and metal stents, particularly in cardiovascular and urological surgeries.
How are stents inserted during surgery?
Stents are typically inserted through a catheter during a minimally invasive procedure, such as angioplasty or endoscopic surgery.
Can stents be used for non-cardiovascular surgeries?
Yes, stents are used in various surgeries, including urological and gastrointestinal procedures, to support blocked or narrowed passages.
What is the difference between drug-eluting and bare-metal stents?
Drug-eluting stents release medication to prevent artery re-narrowing, while bare-metal stents are plain metal structures without medication.
How does the aging population affect the surgical stents market?
The aging population increases the prevalence of chronic diseases, thereby driving demand for stent-based treatments and surgeries.
Are there alternative treatments to surgical stents?
In some cases, balloon angioplasty or bypass surgery may be alternatives to stent placement, depending on the patient's condition.
What is the future of the surgical stents market?
The future of the surgical stents market looks promising, with ongoing innovations in stent materials, designs, and drug-eluting technologies improving patient outcomes.